Pulmatrix Inc (PULM)

Currency in USD
1.3500
-0.0500(-3.57%)
Closed·
1.35000.0000(0.00%)
·
Earnings results expected in 13 days
PULM is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
1.35001.3836
52 wk Range
1.16009.3700
Key Statistics
Prev. Close
1.4
Open
1.38
Day's Range
1.35-1.3836
52 wk Range
1.16-9.37
Volume
5.65K
Average Volume (3m)
48.77K
1-Year Change
-79.3205%
Book Value / Share
1.04
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
PULM Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Suffers from weak gross profit margins

Pulmatrix Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Sell
Technical Indicators
Sell
Moving Averages
Sell

Pulmatrix, Inc., a biopharmaceutical company, focused on development of novel inhaled therapeutic products to prevent and treat migraine and respiratory diseases with unmet medical needs in the United States. The company offers iSPERSE, an engineered dry powder delivery platform, which enables delivery of small or large molecule drugs to the lungs by inhalation for local or systemic applications. It engages in developing PUR1800, a narrow spectrum kinase inhibitor completed Phase 1b clinical trials for the treatment of acute exacerbations in chronic obstructive pulmonary disease; PUR1900 for the treatment of allergic bronchopulmonary aspergillosis in patients with asthma and cystic fibrosis; and PUR3100, an iSPERSE formulation of dihydroergotamine which is in Phase 1 for the treatment of acute migraine. It has a license agreement with RespiVert Ltd. for access to a portfolio of kinase inhibitor compounds. The company was founded in 2003 and is headquartered in Framingham, Massachusetts.

Compare PULM to Peers and Sector

Metrics to compare
PULM
Peers
Sector
Relationship
P/E Ratio
−1.0x−8.6x−0.5x
PEG Ratio
−0.02−1.320.00
Price/Book
1.3x4.0x2.6x
Price / LTM Sales
-8.0x3.2x
Upside (Analyst Target)
-147.3%47.4%
Fair Value Upside
Unlock7.3%7.7%Unlock
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate

Earnings

Latest Release
26/02/2026
EPS / Forecast
-0.25 / --
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

People Also Watch

0.4222
CISS
-1.84%
8.8300
SVRN
-2.00%
2.290
AIFF
+11.17%
0.801
CREG
+25.16%
8.570
UGRO
-7.75%

FAQ

What Is the Pulmatrix (NASDAQ: PULM) Share Price Today?

The Pulmatrix stock price today is 1.3500 USD.

What Stock Exchange Does Pulmatrix (PULM) Trade On?

Pulmatrix is listed and trades on the Nasdaq Stock Exchange.

What Is the Ticker (Stock Symbol) for Pulmatrix?

The stock symbol (also called a 'ticker') for Pulmatrix is "PULM."

What Is the Current Pulmatrix Market Capitalisation?

As of today, Pulmatrix (NASDAQ: PULM) market cap is 4.9300M USD.

What Is Pulmatrix's (PULM) Earnings Per Share (TTM)?

The Pulmatrix EPS is currently -1.4134 (Trailing Twelve Months).

When Is the Next Pulmatrix Earnings Date?

Pulmatrix's next earnings report will be released on 08/05/2026.

Is PULM a Buy or Sell From a Technical Analyst Perspective?

Based on today's Pulmatrix moving averages and other technical indicators, the daily buy/sell signal for PULM stock is Sell.

How Many Times Has Pulmatrix Stock Split?

Pulmatrix has split 3 times. (See the PULM stock split history page for full effective split date and price information.)

How Many Employees Does Pulmatrix Have?

Pulmatrix has 2 employees, based on their latest Companies House report.

What is the current trading status of Pulmatrix (NASDAQ: PULM)?

As of 25/04/2026, Pulmatrix (PULM) is trading at a share price of 1.3500 USD, with a previous close of 1.4000 USD. The stock has fluctuated within a day range of 1.3500 USD to 1.3836 USD, while its 52-week range spans from 1.1600 USD to 9.3700 USD.

What Is the PULM Premarket Price?

PULM's last pre-market stock price is 1.3800 USD. The pre-market share volume is 330.0000, and the stock has decreased by -0.0200, or -1.4300%.

Industry Spotlight

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.